Pigmented Lesion Treatment MarketThe pigmented lesion treatment market is set to expand from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, growing at a CAGR of 7.8% over the forecast ...
mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback